FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Petr Jansa

Research Profile

Living Beings

Chemicals & Drugs

Concepts & Ideas

Phenomena

Magnetic Resonance Spectroscopy

Physiology

Genes & Molecular Sequences

Genes, MHC Class I

Anatomy

Co-author Network

Publications

TOP 3
Marcela Krecmerová; Johan Neyts; Petra Sázelová; George Stepan; Joeri Auwerx; Martin Dračínský; Nesya Goris; Petr Jansa; Václav Kašička; Eleonóra Kiss; Zlatko Janeba
9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro.
Zdenek Zídek; Eva Kmoníčková; Petra Kostecká; Petr Jansa
Microfiltration method of removal of bacterial contaminants and their monitoring by nitric oxide and Limulus assays.
Eliška Procházková; Anna Březinová; Lucie Cechová; Antonín Holý; Petr Jansa; Helena Mertlíková-Kaiserová; Martin Dračínský
Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Petr Jansa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marcela Krecmerová; Johan Neyts; Petra Sázelová; George Stepan; Joeri Auwerx; Martin Dračínský; Nesya Goris; Petr Jansa; Václav Kašička; Eleonóra Kiss; Zlatko Janeba
9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and its prodrugs: optimized preparation, including identification of by-products formed, and antiviral evaluation in vitro.
Bioorganic & medicinal chemistry 2013;21(5):1199-208.
2013: Zdenek Zídek; Eva Kmoníčková; Petra Kostecká; Petr Jansa
Microfiltration method of removal of bacterial contaminants and their monitoring by nitric oxide and Limulus assays.
Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society 2013;28():1-7.
2012: Eliška Procházková; Anna Březinová; Lucie Cechová; Antonín Holý; Petr Jansa; Helena Mertlíková-Kaiserová; Martin Dračínský
Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening.
Bioorganic & medicinal chemistry letters 2012;22(20):6405-9.
2012: Jiří Blažek; Martin Drančínský; Antonín Holý; Petr Jansa; Martin Maxmilian Kaiser; Marcela Krečmerová; Miroslav Otmar; Ondřej Baszczyňski; Blanka Králová
An enzymatic glycosylation of nucleoside analogues using β-galactosidase from Escherichia coli.
Bioorganic & medicinal chemistry 2012;20(9):3111-8.
2012: Eliška Procházková; Petr Jansa; Lucie Cechová; Martin Dračínský
Long-range heteronuclear coupling constants in 2,6-disubstituted purine derivatives.
Magnetic resonance in chemistry : MRC 2012;50(4):295-8.
2012: David Homolka; Petr Jansa; Jiri Forejt
Genetically enhanced asynapsis of autosomal chromatin promotes transcriptional dysregulation and meiotic failure.
Chromosoma 2012;121(1):91-104.
2011: Petr Jansa; Richard Mackman; George Stepan; Ivan Votruba; Zdeněk Zídek; Gina Bahador; Ondřej Baszczyňski; Tomas Cihlar; Martin Dračínský; Antonín Holý; Zlatko Janeba
A novel and efficient one-pot synthesis of symmetrical diamide (bis-amidate) prodrugs of acyclic nucleoside phosphonates and evaluation of their biological activities.
European journal of medicinal chemistry 2011;46(9):3748-54.
2011: Jana Jirásková-Vaníčková; Rüdiger Ettrich; Barbora Vorlová; Hillary E Hoffman; Martin Lepšík; Petr Jansa; Jan Konvalinka
Inhibition of human serine racemase, an emerging target for medicinal chemistry.
Current drug targets 2011;12(7):1037-55.
2011: Ondřej Baszczyňski; Petr Jansa; Martin Dračínský; Blanka Klepetářová; Antonín Holý; Ivan Votruba; Erik de Clercq; Jan Balzarini; Zlatko Janeba
Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines.
Bioorganic & medicinal chemistry 2011;19(7):2114-24.
2011: David Homolka; Robert Ivanek; Jiri Forejt; Petr Jansa
Differential expression of non-coding RNAs and continuous evolution of the X chromosome in testicular transcriptome of two mouse species.
PloS one 2011;6(2):e17198.
2008: Michal Pravenec; Ludmila Kazdova; Vladimir Landa; Vaclav Zidek; Petr Mlejnek; Miroslava Simakova; Petr Jansa; Jiri Forejt; Vladimír Kren; Drahomira Krenova; Nianning Qi; Jia-Ming Wang; Derrick Chan; Timothy J Aitman; theodore kurtz
Identification of mutated Srebf1 as a QTL influencing risk for hepatic steatosis in the spontaneously hypertensive rat.
Hypertension 2008;51(1):148-53.
2007: Radim Nencka; Ivan Votruba; Hubert Hrebabecký; Petr Jansa; Eva Tloust'ová; Kveta Horská; Milena Masojídková; Antonín Holý
Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase.
Journal of medicinal chemistry 2007;50(24):6016-23.
2007: David Homolka; Robert Ivanek; Jana Capkova; Petr Jansa; Jiri Forejt
Chromosomal rearrangement interferes with meiotic X chromosome inactivation.
Genome research 2007;17(10):1431-7.
2007: Jirí Hanusek; Mark A Russell; Andrew P Laws; Petr Jansa; John H Atherton; Kevin Fettes; Michael I Page
Mechanism of the sulfurisation of phosphines and phosphites using 3-amino-1,2,4-dithiazole-5-thione (xanthane hydride).
Organic & biomolecular chemistry 2007;5(3):478-84.
2007: Petr Jansa; Vladimír Machácek; Petr Nachtigall; Vladimír Wsól; Markéta Svobodová
Coordination compounds based on 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid.
Molecules (Basel, Switzerland) 2007;12(5):1064-79.
2005: Petr Jansa; Petr Divina; Jiri Forejt
Construction and characterization of a genomic BAC library for the Mus m. musculus mouse subspecies (PWD/Ph inbred strain).
BMC genomics 2005;6():161.
2003: Michal Pravenec; Ludmila Kazdová; Vladimir Landa; Vaclav Zidek; Petr Mlejnek; Petr Jansa; Jiaming Wang; Nianning Qi; theodore kurtz
Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat.
The Journal of biological chemistry 2003;278(46):45209-15.
2003: Petr Jansa; Jiri Hatina
The inverted CCAAT motif is an indispensable element of the enhancer B of the mouse major histocompatibility I H2-Kb gene.
DNA and cell biology 2003;22(1):55-64.
2002: Jiri Hatina; Petr Jansa; Josef Reischig
Transcription factor NF-IL6 (C/EBPbeta) activates the expression of the mouse MHC class I H2-Kb gene in response to TNF-alpha via the intragenic downstream regulatory element.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2002;22(7):741-9.
2001: Michal Pravenec; Petr Jansa; Vlastimil Kostka; Václav Zídek; Vladimír Kren; Jiri Forejt; theodore kurtz
Identification of a mutation in ADD1/SREBP-1 in the spontaneously hypertensive rat.
Mammalian genome : official journal of the International Mammalian Genome Society 2001;12(4):295-8.
2000: Jiri Hatina; Petr Jansa; Jiri Forejt
The nomenclature of major histocompatibility complex class I gene regulatory regions -- the case of two different downstream regulatory elements.
Molecular immunology 2000;37(12-13):799-800.